Cargando…
Urokinase receptor promotes ovarian cancer cell dissemination through its 84-95 sequence
The clinical relevance of the urokinase receptor (uPAR) as a prognostic marker in ovarian cancer is well documented. We have shown that the uPAR sequence corresponding to 84-95 residues, linking D1 and D2 domains (uPAR(84-95)), drives cell migration and angiogenesis in a protease-independent manner....
Autores principales: | Bifulco, Katia, Votta, Giuseppina, Ingangi, Vincenzo, Carluccio, Gioconda Di, Rea, Domenica, Losito, Simona, Montuori, Nunzia, Ragno, Pia, Stoppelli, Maria Patrizia, Arra, Claudio, Carriero, Maria Vincenza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147313/ https://www.ncbi.nlm.nih.gov/pubmed/24980826 |
Ejemplares similares
-
Single Amino Acid Substitutions in the Chemotactic Sequence of Urokinase Receptor Modulate Cell Migration and Invasion
por: Bifulco, Katia, et al.
Publicado: (2012) -
Cyclization of the Urokinase Receptor-Derived Ser-Arg-Ser-Arg-Tyr Peptide Generates a Potent Inhibitor of Trans-Endothelial Migration of Monocytes
por: Yousif, Ali Munaim, et al.
Publicado: (2015) -
Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas
por: Carriero, Maria Vincenza, et al.
Publicado: (2017) -
The urokinase receptor-derived cyclic peptide [SRSRY] suppresses neovascularization and intravasation of osteosarcoma and chondrosarcoma cells
por: Ingangi, Vincenzo, et al.
Publicado: (2016) -
Therapeutic Strategies Targeting Urokinase and Its Receptor in Cancer
por: Masucci, Maria Teresa, et al.
Publicado: (2022)